Clinical Trials

NCT04645602 | RECRUITING | PHASE2
20 participants

Merck IIT: RRP Pembro and Lenvatinib

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-02
Start Date:
2025-07-18
Completion:
2027-12-31
Conditions
  • Human Papilloma Virus
  • Recurrent Respiratory Papillomatosis
  • Pulmonary Disease
Interventions
  • DRUG
No Results Yet
NCT04576117 | ACTIVE_NOT_RECRUITING | PHASE3
300 participants

A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-02
Start Date:
2021-02-16
Completion:
2026-12-30
Conditions
  • Recurrent Low Grade Astrocytoma
  • Recurrent WHO Grade 2 Glioma
  • Refractory Low Grade Astrocytoma
  • Refractory Low Grade Glioma
  • Refractory WHO Grade 1 Glioma
Interventions
  • PROCEDURE
  • OTHER
  • DRUG
No Results Yet
NCT04214067 | ACTIVE_NOT_RECRUITING | PHASE3
164 participants

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to the Usual Radiation Treatment for Newly Diagnosed Early Stage High Intermediate Risk Endometrial Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-02
Start Date:
2020-04-09
Completion:
2025-12-30
Conditions
  • Endometrial Endometrioid Adenocarcinoma
  • Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
  • Stage II Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Interventions
  • PROCEDURE
  • RADIATION
  • BIOLOGICAL
  • OTHER
No Results Yet
NCT03952585 | ACTIVE_NOT_RECRUITING | PHASE2/PHASE3
384 participants

De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer

Study Type:
INTERVENTIONAL
Last Updated:
2026-07-02
Start Date:
2019-10-09
Completion:
2024-03-01
Conditions
  • Basaloid Squamous Cell Carcinoma
  • Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Oropharyngeal Squamous Cell Carcinoma
  • Papillary Squamous Cell Carcinoma
  • Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Pathologic Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
  • Squamous Cell Carcinoma
Interventions
  • PROCEDURE
  • DRUG
  • OTHER
  • RADIATION
  • BIOLOGICAL
Previous
Sorted by latest updates
Next
Showing 40 trials per page